Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
16.27
-0.37 (-2.22%)
At close: Sep 17, 2025, 4:00 PM EDT
16.63
+0.36 (2.21%)
After-hours: Sep 17, 2025, 5:52 PM EDT
Pulse Biosciences Market Cap
Pulse Biosciences has a market cap or net worth of $1.09 billion as of September 17, 2025. Its market cap has decreased by -7.30% in one year.
Market Cap
1.09B
Enterprise Value
996.80M
1-Year Change
-7.30%
Ranking
Category
Stock Price
$16.27
Market Cap Chart
Since May 18, 2016, Pulse Biosciences's market cap has increased from $52.40M to $1.09B, an increase of 1,989.51%. That is a compound annual growth rate of 38.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 1.12B | 4.53% |
| Dec 31, 2024 | 1.07B | 59.11% |
| Dec 29, 2023 | 673.10M | 552.86% |
| Dec 30, 2022 | 103.10M | -76.50% |
| Dec 31, 2021 | 438.80M | -27.42% |
| Dec 31, 2020 | 604.60M | 116.86% |
| Dec 31, 2019 | 278.80M | 43.19% |
| Dec 31, 2018 | 194.70M | -49.52% |
| Dec 29, 2017 | 385.70M | 345.90% |
| Dec 30, 2016 | 86.50M | 65.08% |
| May 18, 2016 | 52.40M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |